ARDS following equine ATG therapy.
D000818:Animals; D000961:Antilymphocyte Serum / Q000009:adverse effects*; D006736:Horses; D006801:Humans; D008297:Male; D008875:Middle Aged; D012128:Respiratory Distress Syndrome / Q000209:etiology*; D013601:T-Lymphocytes / Q000276:immunology*
D000961:Antilymphocyte Serum